相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TOPK promotes epithelial-mesenchymal transition and invasion of breast cancer cells through upregulation of TBX3 in TGF-β1/Smad signaling
Young-Ju Lee et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2020)
PBK as a Potential Biomarker Associated with Prognosis of Glioblastoma
Chengyuan Dong et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2020)
Establishment and Characterization of a Recurrent Osteosarcoma Cell Line: OSA 1777
Pichaya Thanindratarn et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2020)
Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models
Andrew T. Stefka et al.
CANCER MEDICINE (2020)
The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma
Marilyn Heng et al.
EUROPEAN JOURNAL OF CANCER (2020)
BGN/TLR4/NF-κB Mediates Epigenetic Silencing of Immunosuppressive Siglec Ligands in Colon Cancer Cells
Hsiang-Chi Huang et al.
CELLS (2020)
SynergyFinder 2.0: visual analytics of multi-drug combination synergies
Aleksandr Ianevski et al.
NUCLEIC ACIDS RESEARCH (2020)
Suppression of the solar ultraviolet-induced skin carcinogenesis by TOPK inhibitor HI-TOPK-032
Eunmiri Roh et al.
ONCOGENE (2020)
LIN28B promotes neuroblastoma metastasis and regulates PDZ binding kinase
Dongdong Chen et al.
NEOPLASIA (2020)
T-LAK cell-originated protein kinase (TOPK) is a Novel Prognostic and Therapeutic Target in Chordoma
Pichaya Thanindratarn et al.
CELL PROLIFERATION (2020)
MAGE-A3 Is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma
Anthony P. Conley et al.
CANCERS (2019)
GENT2: an updated gene expression database for normal and tumor tissues
Seung-Jin Park et al.
BMC MEDICAL GENOMICS (2019)
Advances in immune checkpoint inhibitors for bone sarcoma therapy
Pichaya Thanindratarn et al.
JOURNAL OF BONE ONCOLOGY (2019)
Therapeutic Targets for Bone and Soft-Tissue Sarcomas
Shinji Miwa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Efficacy and safety of regorafenib in adult patients with metastatic osteosarcoma: a non-comparative, randomised, double-blind, placebo-controlled, phase 2 study
Florence Duffaud et al.
LANCET ONCOLOGY (2019)
Current and future therapeutic approaches for osteosarcoma
Douglas J. Harrison et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2018)
Targeting PRPK and TOPK for skin cancer prevention and therapy
Eunmiri Roh et al.
ONCOGENE (2018)
Immunotherapy for osteosarcoma: Where do we go from here?
Mary F. Wedekind et al.
PEDIATRIC BLOOD & CANCER (2018)
Tissue microarrays - translational biomarker research in the fast lane
Felix Behling et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2018)
Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays
Tzu-Cheng Su et al.
PLOS ONE (2018)
T-LAK cell-originated protein kinase (TOPK): an emerging target for cancer-specific therapeutics
Katharine J. Herbert et al.
CELL DEATH & DISEASE (2018)
The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis
Tatyana A. Zykova et al.
EBIOMEDICINE (2017)
TOPK (T-LAK cell-originated protein kinase) inhibitor exhibits growth suppressive effect on small cell lung cancer
Jae-Hyun Park et al.
CANCER SCIENCE (2017)
Exploring cancer genomic data from the cancer genome atlas project
Ju-Seog Lee
BMB REPORTS (2016)
T-LAK Cell-Originated Protein Kinase (TOPK) as a Prognostic Factor and a Potential Therapeutic Target in Ovarian Cancer
Yuji Ikeda et al.
CLINICAL CANCER RESEARCH (2016)
Oncogenic roles of TOPK and MELK, and effective growth suppression by small molecular inhibitors in kidney cancer cells
Taigo Kato et al.
ONCOTARGET (2016)
Prognostic factors for survival in patients with high-grade osteosarcoma using the Surveillance, Epidemiology, and End Results (SEER) Program database
Kyle R. Duchman et al.
CANCER EPIDEMIOLOGY (2015)
Microfluidic 3D cell culture: from tools to tissue models
Vincent van Duinen et al.
CURRENT OPINION IN BIOTECHNOLOGY (2015)
Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo
Mrinal Joel et al.
MOLECULAR CANCER (2015)
PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion
Joshua D. Brown-Clay et al.
ONCOTARGET (2015)
Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteins
Raed Rizkallah et al.
ONCOTARGET (2015)
Searching for Drug Synergy in Complex Dose-Response Landscapes Using an Interaction Potency Model
Bhagwan Yadav et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2015)
3D Cell Culture Systems: Advantages and Applications
Maddaly Ravi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2015)
TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis
Yo Matsuo et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem-like cells
Radek Fedr et al.
CYTOMETRY PART A (2013)
The Genotype-Tissue Expression (GTEx) project
John Lonsdale et al.
NATURE GENETICS (2013)
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study
G. Grignani et al.
ANNALS OF ONCOLOGY (2012)
Cancer bioinformatics: A new approach to systems clinical medicine
Duojiao Wu et al.
BMC BIOINFORMATICS (2012)
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Jordi Barretina et al.
NATURE (2012)
TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer
M-C Shih et al.
ONCOGENE (2012)
Measurement of mRNA abundance using RNA-seq data: RPKM measure is inconsistent among samples
Gunter P. Wagner et al.
THEORY IN BIOSCIENCES (2012)
Osteosarcoma Incidence and Survival Rates From 1973 to 2004 Data From the Surveillance, Epidemiology, and End Results Program
Lisa Mirabello et al.
CANCER (2009)
TOPK promotes tumour cell proliferation through p38MAPK activity and regulation of the DNA damage response
V. Ayllon et al.
ONCOGENE (2007)
Methods and goals for the use of in vitro and in vivo chemosensitivity testing
Rosalyn D. Blumenthal et al.
MOLECULAR BIOTECHNOLOGY (2007)
Development of resistance to chemotherapeutic drugs in human osteosarcoma cell lines largely depends on up-regulation of clusterin/apolipoprotein J
Magda Lourda et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Clonogenic assay of cells in vitro
Nicolaas A. P. Franken et al.
NATURE PROTOCOLS (2006)
分享论文
